secwatch.observer — SEC 8-K summary
======================================

Issuer:     VIEMED HEALTHCARE, INC. (VMD)
CIK:        0001729149
Form:       8-K
Filed at:   2022-08-02T23:59:59+00:00
Accession:  0001729149-22-000072
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Viemed Healthcare Q2 2022 core revenue $33.1M record, up 26% YoY; adjusted EBITDA $6.5M
--------------------------------------------------------------------------------

- Q2 core net revenues $33.1M (record); total revenues including COVID-19 services $33.3M.
- Adjusted EBITDA of $6.5M for Q2 2022 and $13.7M for six months ended June 30, 2022.
- Ventilator patient count 8,837, up 9% YoY; highest quarterly growth since Q2 2019.
- Repurchased 1,350,567 shares at avg $5.18 per share, total cost $7.0M.
- Medicare overpayment exposure reduced to $1.1M after reconsideration; appeals filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1729149/000172914922000072/0001729149-22-000072-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1729149/000172914922000072/vmd-20220802.htm
  HTML page:      https://secwatch.observer/filing/0001729149-22-000072

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer